Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Helen C. Koenig"'
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 14 (2015)
In 2012, the US Food and Drug Administration approved Truvada as a pre-exposure prophylaxis (PrEP) for adults at risk of HIV. PrEP is highly effective at preventing HIV when taken daily, but no gold standard exists for consistently administering PrEP
Externí odkaz:
https://doaj.org/article/4ef4306139a94b65b359159198093d26
Publikováno v:
Quality management in health care. 31(3)
There is a paucity of guidance on HIV pre-exposure prophylaxis (PrEP) implementation in an academic medical center. The objectives of this study were to describe interventions by a multidisciplinary PrEP task force at an academic medical center and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce77eea5a18b4b3322c87674baa4ebe4
https://pubmed.ncbi.nlm.nih.gov/35727768
https://pubmed.ncbi.nlm.nih.gov/35727768
Publikováno v:
Patient preference and adherence
Background Despite pre-exposure prophylaxis (PrEP) being highly effective at preventing HIV, HIV infections among individuals prescribed PrEP continue to occur. The vast majority of these new infections occur among individuals with sub-optimal adhere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d340c162913907af05f24dabb54449e
http://europepmc.org/articles/PMC7873020
http://europepmc.org/articles/PMC7873020
Autor:
Sarita Sonalkar, William R. Short, Arden McAllister, Corinne Kete, Leah Ingeno, Jessica Fishman, Helen C. Koenig, Courtney A. Schreiber, Anne M. Teitelman
Publikováno v:
Womens Health Issues
BACKGROUND: Family planning clinical encounters are important opportunities for HIV prevention. Our objectives were 1) to estimate the proportion of patients seeking induced abortion and early pregnancy loss management eligible for HIV pre-exposure p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::116de4ba5d8b5db23ccdb03141f2a0c9
https://europepmc.org/articles/PMC9253197/
https://europepmc.org/articles/PMC9253197/
Autor:
Sarah Williams, Surgeons, Nyc, Ny, Usa, Devon Clark, Caitlin Conyngham, Linden Lalley-Chareczko, Philadelphia Fight, Philadelphia, Pa, Usa, Sahana Jayaraman, Helen C. Koenig
Publikováno v:
HIV/AIDS Research and Treatment – Open Journal. 6:10-21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ed575dcb5c36cfa1fe75bcb3d670017
https://doi.org/10.17140/hartoj-6-130
https://doi.org/10.17140/hartoj-6-130
Publikováno v:
Int J STD AIDS
Background Incidence of syphilis has been rising in recent years and disproportionately affects young adults, racial/ethnic minority men, and people living with HIV. This study describes patterns of syphilis infection and syphilis-related care utiliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ed9e9b480cd376645129de173cf340
https://pubmed.ncbi.nlm.nih.gov/34727755
https://pubmed.ncbi.nlm.nih.gov/34727755
Autor:
José A. Bauermeister, Danielle Petsis, Helen C. Koenig, Linden Lalley-Chareczko, Meghan Swyryn, Nadia Dowshen, Judy A. Shea, Joshua Franklin, Robert E. Gross, Sarah M. Wood
Publikováno v:
AIDS Behav
We aimed to discover barriers and facilitators of HIV pre-exposure prophylaxis (PrEP) adherence in young men and transgender women of color who have sex with men (YMSM/TW). Short-term and sustained adherence were measured by urine tenofovir concentra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79797b3e31e9d51714f966c10b22b176
https://doi.org/10.1007/s10461-019-02502-y
https://doi.org/10.1007/s10461-019-02502-y
Publikováno v:
AIDS Care. 31:1203-1206
Maximizing the impact of HIV pre-exposure prophylaxis (PrEP) requires optimizing access and adherence for those at risk of contracting HIV. This study examined challenges to the processes of accessing and adhering to PrEP encountered by participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2dd8b47642f5ddc4ff1c9d49497834d
https://doi.org/10.1080/09540121.2019.1587369
https://doi.org/10.1080/09540121.2019.1587369
Autor:
Danielle Petsis, Robert E. Gross, Helen C. Koenig, Knashawn H. Morales, Annet Davis, Kezia Barnett, Sarah M. Wood, Nadia Dowshen, Danielle Fiore, David S. Metzger, Ian Frank
Publikováno v:
AIDS Behav
The effects of mental health comorbidities and social support on the HIV pre-exposure prophylaxis (PrEP) care continuum are unknown. We conducted a cross-sectional study of men and transgender individuals, ≥ 18 years-old, with ≥ 2 male or transge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859c49a1aec05a58b41ccbcb5487e4d9
https://europepmc.org/articles/PMC8546869/
https://europepmc.org/articles/PMC8546869/
Autor:
Lane DiFlavis, Linden Lalley-Chareczko, Helen C. Koenig, Rachel A Nahan, Michael T Ramos, Rose Cantor, Devon Clark, Gregory S. Troutman, Lindsay B. Young
Publikováno v:
International journal of STDAIDS. 31(5)
Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF)/emtricitabine is 99% effective in preventing HIV when taken daily. Young men/transgender women of color who have sex with men are the most at risk to become infected with HIV, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a699882b1a6b2542efa1fd91f51adafa
https://pubmed.ncbi.nlm.nih.gov/32208815
https://pubmed.ncbi.nlm.nih.gov/32208815